Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $797.3100 (-1.1%) ($797.2100 - $797.3100) on Wed. Aug. 16, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.7% (three month average) | RSI | 74 | Latest Price | $797.3100(-1.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.3% a day on average for past five trading days. | Weekly Trend | REGN advances 4.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(62%) IBB(59%) DIA(47%) XLF(46%) SPY(45%) | Factors Impacting REGN price | REGN will decline at least -0.85% in a week (0% probabilities). VXX(-44%) VIXM(-39%) USO(-14%) TBT(-12%) EDOC(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.85% (StdDev 1.7%) | Hourly BBV | -2.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $802.52(-0.65%) | 10 Day Moving Average | $789.82(0.95%) | 20 Day Moving Average | $763.69(4.4%) | To recent high | -1.3% | To recent low | 15.2% | Market Cap | $84.538b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |